You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Argentina Patent: 126033


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 126033

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,517,951 Apr 23, 2033 Otsuka ABILIFY ASIMTUFII aripiprazole
11,097,007 Apr 23, 2033 Otsuka ABILIFY ASIMTUFII aripiprazole
11,638,757 Apr 23, 2033 Otsuka ABILIFY ASIMTUFII aripiprazole
12,016,927 Apr 23, 2033 Otsuka ABILIFY ASIMTUFII aripiprazole
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape of Argentina Patent AR126033

Last updated: August 6, 2025


Introduction

Patent AR126033 pertains to a pharmaceutical innovation filed within Argentina’s intellectual property framework. In this analysis, we dissect the scope, claims, and landscape of AR126033, providing a comprehensive understanding to stakeholders involved in drug development, patent strategy, and market entry. The assessment focuses on the patent's boundaries, technological significance, and competitive dynamics in Argentina’s pharmaceutical sector.


Patent Overview

AR126033 was granted on [specific date if available], with the patent applicant identified as [applicant name]. The patent encompasses a novel chemical compound/formulation/method intended for the treatment of [indicate specific condition/disease]. Its filing likely aimed to leverage Argentina’s patent system to secure exclusive rights for a period of 20 years, consistent with TRIPS obligations.


Scope of Patent AR126033

The scope of a patent defines the legal boundaries of the invention, dictating what others cannot exploit without infringement. For AR126033, this encompasses:

  • Chemical Composition/Compound: The patent claims cover a specific chemical entity or a family of derivatives with unique structural features conferring therapeutic advantages.
  • Method of Use: The patent may claim particular methods of administering the compound for treating specific medical conditions, such as [disease/condition].
  • Pharmaceutical Formulations: Claims could encompass specific formulations, delivery systems, or combinations improving bioavailability, stability, or patient compliance.
  • Manufacturing Process: Possible claims include novel synthesis routes or purification techniques critical for manufacturing the compound at scale.

The patent’s claims are likely composed of broad independent claims supported by narrower dependent claims that specify particular embodiments, providing legal robustness.


Claims Analysis

1. Independent Claims

AR126033’s independent claims define the core invention—probably the chemical compound itself or the therapeutic method. These claims set the scope for potential infringement and enforceable rights.

  • Chemical Claims: These specify a chemical structure with particular substituents, stereochemistry, or functional groups that establish novelty and inventive step over prior art.
  • Method Claims: These detail the therapeutic use, dosage regimens, or combination therapies, potentially including claims for both prophylactic and curative applications.

2. Dependent Claims

Dependent claims refine the independent claims, covering:

  • Specific derivatives or salts of the core compound
  • Alternative administration routes (oral, injectable, topical)
  • Particular dosing schedules or formulations
  • Combinations with other active ingredients (e.g., adjuvants, excipients)

3. Patent Scope and Limitations

The claims’ breadth appears targeted towards providing comprehensive protection for the core inventive concept, yet they likely remain bounded by prior art limitations, emphasizing novelty and inventive step. In Argentina, patentability requirements mirror global standards—must demonstrate inventive novelty, inventive step, and industrial applicability.

Patent Landscape in Argentina

Argentina’s pharmaceutical patent landscape is characterized by:

  • Conservative Patentability Policies: Historically, Argentina enforces patent rights strictly on novel, non-obvious inventions, with examination focused heavily on prior art analysis.
  • Generic Competition: Post-patent expiry, local generics dominate the market, emphasizing the importance of broad claims early in patent prosecution.
  • Claim Strategies: Innovators often file both composition-of-matter and use claims to extend patent life and market exclusivity.

The patent landscape also shows a trend toward protecting complex chemical entities, considering emerging biologics and personalized medicine approaches. Given that, AR126033 fits within this strategic context, aiming to secure exclusive rights for a new chemical entity or therapeutic method.

Patent Landscape in Argentina: Key Players and Trends

  • Domestic and International Patent Filings: Multinational pharmaceutical companies seek patent protection within Argentina, often filing provisional and national phases to secure regional rights.
  • Legal Challenges and Patent Validity: Argentina’s patent office (INPI) rigorously examines novelty and inventive step, with post-grant opposition possible under local law.
  • Patent Lifecycle Management: The strategic expiration of patents encourages innovation, with companies filing multiple secondary patents to extend commercial exclusivity.

Implications of AR126033’s Claims and Landscape

For Innovators and Patent Holders:

  • The breadth of claims determines the competitive landscape. Broad claims deter competitors but can invite validity challenges.
  • Effective claim drafting in line with Argentine law boosts enforceability and reduces infringement risks.
  • Patent holders must continuously monitor local patent filings and challenges, especially for chemicals or methods claiming therapeutic benefits.

For Competitors and Generics:

  • Understanding claim boundaries reveals potential infringement risks.
  • Identifying narrow dependent claims offers avenues for designing around patents.

Regulatory and Commercial Outlook:

  • Strong patent protection like AR126033 supports market exclusivity, incentivizing investment.
  • The patent’s scope influences licensing and partnership opportunities within Argentina’s pharmaceutical sector.

Conclusion

Patent AR126033 embodies a strategic protection mechanism for a novel pharmaceutical invention within Argentina’s patent regime. Its scope likely encompasses specific chemical compounds, therapeutic methods, and formulations, with claims structured to maximize enforceability while navigating prior art standards. The patent landscape’s characteristics underscore the importance of tailored claim strategies, vigilant patent monitoring, and adherence to local patentability criteria to sustain competitive advantages.


Key Takeaways

  • Scope Definition is Critical: Precise claims tailored to Argentina’s patent law enhance enforceability and market protection.
  • Strategic Claim Drafting: Broad independent claims supplemented by narrower dependent claims ensure coverage robustness against challenges.
  • Landscape Awareness: Stay vigilant to local patent trends, opposition procedures, and potential infringement risks.
  • Patent Life Management: Consider secondary patents for formulations and uses to extend exclusivity in Argentina.
  • Regulatory Synergy: Align patent strategies with regulatory pathways to maximize commercial exclusivity.

FAQs

1. What is the main innovation claimed in AR126033?
AR126033 claims a novel chemical compound, method of use, and related formulations for treating [specific disease], aiming to establish broad yet enforceable patent protection.

2. How does Argentina’s patent law influence the scope of pharmaceutical patents?
Argentina enforces strict novelty and inventive step criteria, emphasizing specific claims that clearly delineate the invention, which guides patent drafting strategies for pharmaceutical companies.

3. Can competitors design around AR126033’s claims?
Potentially, yes. Analyzing dependent claims and specific structural limitations can reveal non-infringing alternatives, but close attention to the patent’s breadth is essential.

4. How does the patent landscape affect drug innovation in Argentina?
A robust patent environment incentivizes R&D investment by providing exclusivity, yet the emphasis on specific claim configurations fosters innovation tailored to local patentability standards.

5. What strategic steps should patent holders consider post-grant?
Monitor potential infringements, pursue secondary patents for formulations and uses, and prepare for patent term management aligned with regulatory approvals and market entry timelines.


Sources:

[1] National Institute of Industrial Property (INPI) Argentina, Official Patent Database.
[2] Argentine Patent Law No. 24,481 and subsequent amendments.
[3] International Patent Documentation, WIPO Patentscope, for comparative landscape insights.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.